ARPANSA’s Dr Ken Karipidis chaired a committee of the International Commission on Non-Ionising Radiation Protection (ICNIRP) to develop a statement on exposure to non-ionising radiation for cosmetic purposes.
Do you use, or are you exposed to radiation as part of your work? Our new suite of occupational exposure factsheets have been designed to keep you informed about the type of radiation you may be exposed to, any possible health effects and how to adequately protect yourself.
With the novel coronavirus (COVID-19) pandemic, some members of the public are concerned about the human immune system and whether it can be compromised by wireless telecommunications sources such as 5G.
ARPANSA has again collated data from radiation regulators around the country to provide a report on radiation safety and identify opportunities for improvement in the safe use of radiation, particularly in the medical sector.
The radiation dose from a CT scan, while low, is nonetheless assumed to contribute a small additional risk to a patient’s lifetime risk of cancer. ARPANSA's new reference levels show patients in Australia are receiving much lower doses than 5-10 years ago.
In June 2018, ARPANSA issued a direction to its licence holder, the Australian Nuclear Science and Technology Organisation (ANSTO), to initiate an independent review of its approach to occupational radiation safety at its nuclear medicine facility operated by ANSTO Health, now known as Health Products.
Dr Ken Karipidis, ARPANSA’s Assistant Director of Assessment and Advice, recently attended a workshop hosted by the German Federal Office for Radiation Protection (BfS) to explore effects of electric, magnetic and electromagnetic fields on animals and plants.
ARPANSA respectfully acknowledges the Traditional Owners and Custodians of Country throughout Australia and their continuing connection to land, waters and community. We pay our respect to Aboriginal and Torres Strait Islander Peoples, their cultures, and to Elders past and present.